Fulgent Genetics, Inc. FLGT Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Fulgent Genetics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Fulgent Genetics, Inc.'s financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Fulgent Genetics, Inc.'s financing cash flow?
- Fulgent Genetics, Inc. (FLGT) reported financing cash flow of -$44.83M in Q1 2026.
- How has Fulgent Genetics, Inc.'s financing cash flow changed year-over-year?
- Fulgent Genetics, Inc.'s financing cash flow decreased by 301.3% year-over-year, from -$11.17M to -$44.83M.
- What is the long-term trend for Fulgent Genetics, Inc.'s financing cash flow?
- Over 4 years (2021 to 2025), Fulgent Genetics, Inc.'s financing cash flow has grown at a -36.0% compound annual growth rate (CAGR), from $88.39M to -$14.79M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.